+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 1Year
All Genders
Healthy Volunteers
ID06092463

Study of Intestinal Immune System Development and Inflammation in Newborns and Infants Observing Premature Infants and Children Up to 1 Year Undergoing Intestinal Surgery

Led by Rigshospitalet, Denmark · Updated on 2025-05-21

275

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how the human intestinal immune system develops in both premature and mature newborns and exploring the causes of serious early-life gastrointestinal diseases such as necrotising enterocolitis NEC and intestinal atresia. This observational study aims to understand the normal immune development in newborns and how it relates to early feeding practices during the neonatal period. The study includes two groups premature infants born before 32 weeks gestation and newborns or children up to 1 year old undergoing intestinal surgery for atresia. For premature infants, fecal samples are collected starting from day 1 of life weekly until discharge. If NEC develops requiring surgery, intestinal tissue and fecal samples are obtained during surgery and at stoma reversal to study intestinal development and nutritional effects. Similarly, for infants with atresia, fecal and tissue samples are collected during surgery and later stoma reversal when applicable. Participants and their families will provide fecal samples regularly, and, when surgery is needed, intestinal tissue samples will be collected safely. Researchers will analyze immune system development and microbiome changes over time using these samples. Primary outcomes include studying if fecal IgA can be an early NEC marker and tracking intestinal immune system development. Secondary outcomes consider nutritional impact, growth, medical treatments, and bowel habits. Participation involves informed consent, sample collection, and monitoring throughout the infants hospital stay or surgical course, lasting up to one year for some participants.

CONDITIONS

Brief Title

The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease

Research Team

L

Lise Aunsholt, phd

M

Mark Bremholm Ellebæk, ph.d.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here